(AS) TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis.

Medicine and Dentistry

• Rheumatoid Arthritis 100%
• Infliximab 66%
• Patient 66%
• Combination Therapy 50%
• Infusion 50%
• Standing 33%
• Tumor Necrosis Factor 33%
• Endothelial Dysfunction 33%
• Endothelial Function 33%
• Inpatient 33%
• Methotrexate 16%
• Rheumatic Disease 16%
• Cardiovascular Disease 16%
• Biological Marker 16%
• Echography 16%
• Cell Adhesion Molecule 16%
• Vasculotropin 16%
• Alpha Adrenergic Receptor Blocking 16%
• C Reactive Protein 16%
• Endothelial Leukocyte Adhesion Molecule 1 16%
• Brachial Artery 16%
• Vasodilatation 16%
• Tumor Necrosis Factor Antibody 16%
• Symptom 16%
• Cell Adhesion Molecule 1 16%
• Vascular Cell Adhesion Molecule 1 16%
• Therapeutic Procedure 16%
• Aptitude 16%
• Plasma 16%
• Atherosclerosis 16%

Immunology and Microbiology

• Inflammatory Arthritis 100%
• Infliximab 66%
• Flow 50%
• Tumor Necrosis Factor Alpha 33%
• Monoclonals 33%
• Standing 33%
• Methotrexate 16%
• Rheumatic Disease 16%
• Blood Level 16%
• Vasculotropin 16%
• C-Reactive Protein 16%
• Adhesion Molecule 16%
• Atherosclerosis 16%
• Tumor Necrosis Factor Antibody 16%
• Cell Adhesion Molecule 1 16%
• VCAM-1 16%
• Vasodilatation 16%
• Alpha Adrenergic Receptor Blocking 16%
• Brachial Artery 16%
• E-Selectin 16%
• Artery Diameter 16%
• Time 16%
• Aptitude 16%